224 related articles for article (PubMed ID: 27452464)
1. Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures.
Sugaya Y; Yamazaki M; Uchigashima M; Kobayashi K; Watanabe M; Sakimura K; Kano M
Cell Rep; 2016 Aug; 16(5):1405-1415. PubMed ID: 27452464
[TBL] [Abstract][Full Text] [Related]
2. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.
Nyilas R; Gregg LC; Mackie K; Watanabe M; Zimmer A; Hohmann AG; Katona I
Eur J Neurosci; 2009 May; 29(10):1964-78. PubMed ID: 19453631
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
4. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
[TBL] [Abstract][Full Text] [Related]
5. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.
Hutch CR; Hillard CJ; Jia C; Hegg CC
Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800
[TBL] [Abstract][Full Text] [Related]
6. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.
Gregg LC; Jung KM; Spradley JM; Nyilas R; Suplita RL; Zimmer A; Watanabe M; Mackie K; Katona I; Piomelli D; Hohmann AG
J Neurosci; 2012 Jul; 32(28):9457-68. PubMed ID: 22787031
[TBL] [Abstract][Full Text] [Related]
7. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors.
Marrs WR; Blankman JL; Horne EA; Thomazeau A; Lin YH; Coy J; Bodor AL; Muccioli GG; Hu SS; Woodruff G; Fung S; Lafourcade M; Alexander JP; Long JZ; Li W; Xu C; Möller T; Mackie K; Manzoni OJ; Cravatt BF; Stella N
Nat Neurosci; 2010 Aug; 13(8):951-7. PubMed ID: 20657592
[TBL] [Abstract][Full Text] [Related]
8. Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility.
Guggenhuber S; Romo-Parra H; Bindila L; Leschik J; Lomazzo E; Remmers F; Zimmermann T; Lerner R; Klugmann M; Pape HC; Lutz B
Int J Neuropsychopharmacol; 2015 Aug; 19(2):. PubMed ID: 26232789
[TBL] [Abstract][Full Text] [Related]
9. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.
Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F
J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460
[TBL] [Abstract][Full Text] [Related]
10. CB
Hegyi Z; Oláh T; Kőszeghy Á; Piscitelli F; Holló K; Pál B; Csernoch L; Di Marzo V; Antal M
Sci Rep; 2018 Jul; 8(1):10562. PubMed ID: 30002493
[TBL] [Abstract][Full Text] [Related]
11. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.
Lafourcade M; Elezgarai I; Mato S; Bakiri Y; Grandes P; Manzoni OJ
PLoS One; 2007 Aug; 2(8):e709. PubMed ID: 17684555
[TBL] [Abstract][Full Text] [Related]
12. Molecular composition of the endocannabinoid system at glutamatergic synapses.
Katona I; Urbán GM; Wallace M; Ledent C; Jung KM; Piomelli D; Mackie K; Freund TF
J Neurosci; 2006 May; 26(21):5628-37. PubMed ID: 16723519
[TBL] [Abstract][Full Text] [Related]
13. The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.
Gomez O; Arevalo-Martin A; Garcia-Ovejero D; Ortega-Gutierrez S; Cisneros JA; Almazan G; Sánchez-Rodriguez MA; Molina-Holgado F; Molina-Holgado E
Glia; 2010 Dec; 58(16):1913-27. PubMed ID: 20878765
[TBL] [Abstract][Full Text] [Related]
14. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor.
Yoshida T; Fukaya M; Uchigashima M; Miura E; Kamiya H; Kano M; Watanabe M
J Neurosci; 2006 May; 26(18):4740-51. PubMed ID: 16672646
[TBL] [Abstract][Full Text] [Related]
15. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.
Mátyás F; Urbán GM; Watanabe M; Mackie K; Zimmer A; Freund TF; Katona I
Neuropharmacology; 2008 Jan; 54(1):95-107. PubMed ID: 17655884
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids drive the acquisition of an alternative phenotype in microglia.
Mecha M; Feliú A; Carrillo-Salinas FJ; Rueda-Zubiaurre A; Ortega-Gutiérrez S; de Sola RG; Guaza C
Brain Behav Immun; 2015 Oct; 49():233-45. PubMed ID: 26086345
[TBL] [Abstract][Full Text] [Related]
17. Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus.
Ludányi A; Hu SS; Yamazaki M; Tanimura A; Piomelli D; Watanabe M; Kano M; Sakimura K; Maglóczky Z; Mackie K; Freund TF; Katona I
Neuroscience; 2011 Feb; 174():50-63. PubMed ID: 21035522
[TBL] [Abstract][Full Text] [Related]
18. Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus.
Uchigashima M; Yamazaki M; Yamasaki M; Tanimura A; Sakimura K; Kano M; Watanabe M
J Neurosci; 2011 May; 31(21):7700-14. PubMed ID: 21613483
[TBL] [Abstract][Full Text] [Related]
19. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
Shimizu T; Tanaka K; Shimizu S; Higashi Y; Yawata T; Nakamura K; Taniuchi K; Ueba T; Yuri K; Saito M
Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
[TBL] [Abstract][Full Text] [Related]
20. Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch.
Briand-Mésange F; Pons V; Allart S; Masquelier J; Chicanne G; Beton N; Payrastre B; Muccioli GG; Ausseil J; Davignon JL; Salles JP; Chap H
J Biol Chem; 2020 Nov; 295(46):15767-15781. PubMed ID: 32917725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
